HK1183610A1 - PHARMACEUTICAL DOSAGE FORM COMPRISING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL- g )-4-PHENYL-4,9-DIHYDRO-3H-SPIRO[CYCLOHEXANE-1,1-PYRANO[3,4,B]INDOL]-4- AMINE 6--(N-- NN-)-4--49--3H-[-11- [34B]]-4- - Google Patents

PHARMACEUTICAL DOSAGE FORM COMPRISING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL- g )-4-PHENYL-4,9-DIHYDRO-3H-SPIRO[CYCLOHEXANE-1,1-PYRANO[3,4,B]INDOL]-4- AMINE 6--(N-- NN-)-4--49--3H-[-11- [34B]]-4-

Info

Publication number
HK1183610A1
HK1183610A1 HK13109588.4A HK13109588A HK1183610A1 HK 1183610 A1 HK1183610 A1 HK 1183610A1 HK 13109588 A HK13109588 A HK 13109588A HK 1183610 A1 HK1183610 A1 HK 1183610A1
Authority
HK
Hong Kong
Prior art keywords
pyrano
indol
spiro
dihydro
cyclohexane
Prior art date
Application number
HK13109588.4A
Other languages
English (en)
Chinese (zh)
Inventor
Nadja Grning
Marc Schiller
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43446583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1183610(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HK1183610A1 publication Critical patent/HK1183610A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK13109588.4A 2010-08-04 2013-08-16 PHARMACEUTICAL DOSAGE FORM COMPRISING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL- g )-4-PHENYL-4,9-DIHYDRO-3H-SPIRO[CYCLOHEXANE-1,1-PYRANO[3,4,B]INDOL]-4- AMINE 6--(N-- NN-)-4--49--3H-[-11- [34B]]-4- HK1183610A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37063410P 2010-08-04 2010-08-04
EP10008115 2010-08-04
PCT/EP2011/003918 WO2012016703A2 (fr) 2010-08-04 2011-08-04 Forme galénique pharmaceutique comprenant 6'-fluoro-(n-méthyl- or n,n-diméthyl-)-4-phényl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Publications (1)

Publication Number Publication Date
HK1183610A1 true HK1183610A1 (en) 2014-01-03

Family

ID=43446583

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13109588.4A HK1183610A1 (en) 2010-08-04 2013-08-16 PHARMACEUTICAL DOSAGE FORM COMPRISING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL- g )-4-PHENYL-4,9-DIHYDRO-3H-SPIRO[CYCLOHEXANE-1,1-PYRANO[3,4,B]INDOL]-4- AMINE 6--(N-- NN-)-4--49--3H-[-11- [34B]]-4-

Country Status (28)

Country Link
EP (1) EP2600838B1 (fr)
JP (1) JP5792301B2 (fr)
KR (1) KR101788535B1 (fr)
CN (1) CN103153282B (fr)
AR (1) AR082559A1 (fr)
AU (1) AU2011287873B2 (fr)
BR (1) BR112013004055A2 (fr)
CA (1) CA2802767C (fr)
CL (1) CL2012003584A1 (fr)
CO (1) CO6640316A2 (fr)
DK (1) DK2600838T3 (fr)
EC (1) ECSP13012421A (fr)
ES (1) ES2553742T3 (fr)
HK (1) HK1183610A1 (fr)
HR (1) HRP20151289T1 (fr)
HU (1) HUE025322T2 (fr)
IL (1) IL223881A (fr)
MX (1) MX2013000980A (fr)
NZ (1) NZ604662A (fr)
PE (1) PE20131108A1 (fr)
PL (1) PL2600838T3 (fr)
PT (1) PT2600838E (fr)
RS (1) RS54438B1 (fr)
RU (1) RU2589830C2 (fr)
SI (1) SI2600838T1 (fr)
TW (1) TWI522360B (fr)
WO (1) WO2012016703A2 (fr)
ZA (1) ZA201209501B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE039328T2 (hu) 2010-08-04 2018-12-28 Gruenenthal Gmbh 6'-Fluor-(N-metil- vagy N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro[ciklohexán-1,1'pirano[3,4,B]indol]-4-amin összetételû gyógyszerészeti adagolási forma a neuropátiás fájdalom kezelésére
SI2797924T1 (sl) * 2011-12-12 2016-08-31 Gruenenthal Gmbh Trdne oblike (1r,4r)-6'-fluoro-N,N-dimetil-4-fenil-4',9'-dihidro-3'H-spiro (ciklo-heksan-1,1'-pirano(3,4,b)indol)-4-amina in žveplove kisline
ES2605786T3 (es) * 2011-12-12 2017-03-16 Grünenthal GmbH Formas sólidas de clorhidrato de (1R,4R)-6'-fluor-N,N-dimetil-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4b]indol]-4-amina
US8912226B2 (en) * 2012-05-18 2014-12-16 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
US9320725B2 (en) * 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
US9308196B2 (en) * 2012-05-18 2016-04-12 Gruenenthal Gmbh Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
US20130310385A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US9345689B2 (en) * 2012-05-18 2016-05-24 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
US20130310435A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9855286B2 (en) * 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
TW201642853A (zh) 2015-01-23 2016-12-16 歌林達有限公司 用於治療肝功能之損傷及／或腎功能之損傷個體疼痛之西博帕多（Ｃｅｂｒａｎｏｐａｄｏｌ）
EP3253374B1 (fr) 2015-02-02 2018-11-28 ratiopharm GmbH Composition comprenant du cebranopadol sous forme dissoute
BR112018017167A2 (pt) 2016-02-29 2019-01-02 Gruenenthal Gmbh titulação de cebranopadol
EP3613747A1 (fr) * 2018-08-24 2020-02-26 Grünenthal GmbH Formes cristallines de la trans-6'-fluoro-n-méthyl-4-phényl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
RU2765946C1 (ru) * 2021-03-11 2022-02-07 Графт Полимер Айпи Лимитед Система доставки сверхнасыщаемых самонаноэмульгирующихся лекарственных средств (SNEDDS) для слаборастворимых в воде фармацевтических композиций и способ ее приготовления
WO2024129782A1 (fr) 2022-12-12 2024-06-20 Park Therapeutics, Inc. Régimes et compositions utiles dans le soulagement de la douleur
WO2024173714A1 (fr) 2023-02-15 2024-08-22 Park Therapeutics, Inc. Régimes et compositions utiles dans le soulagement de la douleur

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01011981A (es) * 1999-05-24 2003-09-04 Sonus Pharma Inc Vehiculo de emulsion para farmacos poco solubles.
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102005005446A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
EP1903866B1 (fr) * 2005-11-07 2016-04-06 Murty Pharmaceuticals, Inc. Administration amelioree de tetrahydrocannabinol
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz

Also Published As

Publication number Publication date
HUE025322T2 (en) 2016-02-29
AR082559A1 (es) 2012-12-19
ES2553742T3 (es) 2015-12-11
KR20130095270A (ko) 2013-08-27
RU2013109136A (ru) 2014-09-10
JP2013532699A (ja) 2013-08-19
ZA201209501B (en) 2013-08-28
EP2600838A2 (fr) 2013-06-12
BR112013004055A2 (pt) 2018-04-24
WO2012016703A3 (fr) 2012-08-16
CO6640316A2 (es) 2013-03-22
PT2600838E (pt) 2015-11-17
KR101788535B1 (ko) 2017-10-20
PE20131108A1 (es) 2013-10-17
JP5792301B2 (ja) 2015-10-07
CN103153282A (zh) 2013-06-12
AU2011287873A1 (en) 2013-01-24
NZ604662A (en) 2014-08-29
DK2600838T3 (en) 2015-10-05
HRP20151289T1 (hr) 2016-01-01
RU2589830C2 (ru) 2016-07-10
RS54438B1 (en) 2016-06-30
TWI522360B (zh) 2016-02-21
TW201209059A (en) 2012-03-01
MX2013000980A (es) 2013-02-15
EP2600838B1 (fr) 2015-09-16
WO2012016703A2 (fr) 2012-02-09
CN103153282B (zh) 2015-08-19
IL223881A (en) 2017-01-31
CA2802767A1 (fr) 2011-12-09
PL2600838T3 (pl) 2016-02-29
CA2802767C (fr) 2019-08-13
CL2012003584A1 (es) 2013-02-01
SI2600838T1 (sl) 2015-12-31
ECSP13012421A (es) 2013-03-28
AU2011287873B2 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
HK1183610A1 (en) PHARMACEUTICAL DOSAGE FORM COMPRISING 6-FLUORO-(N-METHYL- OR N,N-DIMETHYL- g )-4-PHENYL-4,9-DIHYDRO-3H-SPIRO[CYCLOHEXANE-1,1-PYRANO[3,4,B]INDOL]-4- AMINE 6--(N-- NN-)-4--49--3H-[-11- [34B]]-4-
HK1183612A1 (en) Pharmaceutical dosage form comprising 6-fluoro-(n-methyl- or n,n-dimethyl- )-4-phenyl-4,9-dihydro-3h-spiro[cylohexane-1,1-pyrano[3,4,b]indol]-4- amine 6--(n-- nn-)-4--49--3h-[-11- [34b]]-4-
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba
DK2129595T3 (da) Drikkevareingredienskapsel
LT2600851T (lt) Farmacinė vaisto forma, apimanti 6`-fluor-(n-metil- arba n,n-dimetil-)-4-fenil-4`,9`-dihidro-3`h-spiro[cikloheksan-1,1`-pirano[3,4,b]indol]-4-aminą, skirta neuropatinio skausmo gydymui
IL207128A0 (en) Pharmaceutical dosage form
IL211400A0 (en) Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
GB0712803D0 (en) Medicament dispenser
ZA200903858B (en) Pharmaceutical dosage form
HK1137363A1 (en) Novel dosage form
PL2154959T3 (pl) Kombinacje grzybobójczych substancji czynnych
EP2341047A4 (fr) Dérivé du cyclohexane et son utilisation pharmaceutique
ZA201300038B (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl-or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
HK1204943A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and a gabapentinoid (1r4r)-6--nn--4--49--3h-[-1 1-[34b]]-4-
HK1204938A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and a nsar (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4- nsar
HK1204944A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and antidepressants (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4-
HK1204939A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and an oxicam (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4-
ZA200710986B (en) Anti-AIDS drug
GB0706970D0 (en) Fermented ingredient

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200729